This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Scheepers, B. D. M. Articles by Rogers, D. G. Search for Related Content PubMed Articles by Scheepers, B. D. M. Articles by Rogers, D. G. Social Bookmarking                         What's this?

Dyskinesias following treatment with 5-HT re-uptake inhibitors

Daniel G. Rogers

Burden Neurological Hospital, Bristol BS12 OBZ, UK

Three cases of dyskinesia attributable to selective serotonergic antidepressant drugs are presented. The patients were not on other medication nor had they been in preceding weeks. The movement disorder disappeared on cessation of the drug within a time period corresponding to the expected wash-out for the different preparations. The emergence of dyskinesic symptoms coincided with a significant deterioration in mental state after an initial good response to the particular medication. Considering the apparently selective action of the serotonin re-uptake inhibitors, these cases suggest that movement disorders and psychiatric symptoms are unlikely to be due to single neurotransmitter mechanisms and that a disturbance of the balance between the different systems is a more likely hypothesis.

Key Words: dyskinesia • movement disorder • 5-HT re-uptake inhibitors • antidepressant • case report

Journal of Psychopharmacology, Vol. 8, No. 4, 258-260 (1994)
DOI: 10.1177/026988119400800409


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?